explore -WSS

explore

author：comprehensive 2025-09-27 16:35:57 - browse：56166

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medical device trials still don't enroll enough women, study finds

hotspot

WSS

Why some fertility treatments produce more boy babies

Achieving telehealth equity for people with hearing loss

Guardant Health colon cancer test endorsed by FDA advisory panel

Beyond aggravation: Constipation is an American epidemic

Congress: Prevent baby formula shortages by passing a new bill

Achieving telehealth equity for people with hearing loss

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

leisure time

Heart attack and stroke risk calculators need revising

New report analyzes digital physical therapy solutions' effectiveness

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Beyond aggravation: Constipation is an American epidemic

Anesthesiologist group: stop taking Ozempic before surgery

Medical students need to learn the potent medicine of empathy

Guidelines to prevent youth baseball injuries need more muscle

The system is set up to fail children with medical complexity

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Unmasking the 'centricity' illusion in clinical trials

entertainment

New report analyzes digital physical therapy solutions' effectiveness

Pharma companies must ensure equitable access to obesity drugs

Report captures long Covid’s disabling effects and policy challenges

My daughter's legacy lives on through her writing, phage therapy

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Curing rare childhood diseases will falter unless Congress steps up

hotspot

hotspot

Wikipedia

leisure time